Intrepid Advises Frontier Dental Laboratories on Its Investment From O2 Investment Partners

Intrepid announced today that it acted as the exclusive financial advisor to Frontier Dental Laboratories (Frontier) on its investment from O2 Investment Partners (O2). The investment by O2 was made in tandem with Frontier’s senior management team who continue to lead the company. Frontier is a full service, multi-national dental laboratory that provides high-end dental prosthetics, removable dental products and implants to hundreds of cosmetic dentists across the world through its two laboratories located in El Dorado Hills, Calif. and Vancouver, B.C., and its sales and marketing office in Los Angeles.

“Congratulations to Brent West, Gil Villavecer, and the entire Frontier team,” said Jonathan Zucker, Managing Director and Head of the Capital Markets Group at Intrepid. “It was a pleasure to collaborate on this transaction with Frontier and their outgoing equity partners Beedie Capital and Paolo Kalaw, one of the dental industry’s most recognized entrepreneurs, who has completed more than 50 dental acquisitions in his career.”

“We selected Intrepid because of their deep industry expertise, and they did a great job finding the right partner for Frontier. This transaction with O2 represents a great opportunity for Brent and Gil to expand Frontier’s technological advantage and embark on an acquisition program across North America,” said Paolo Kalaw, former Chairman of Frontier.

“We are grateful for Intrepid’s support during this fast-moving process,” said David Bell, Director at Beedie Capital. “Their in-depth knowledge of the dental lab industry contributed meaningfully to this excellent outcome.”

With macro tailwinds fanning growth trends in cosmetics, Frontier’s high-end Smile Designs—including crowns and bridges, veneers, as well as single unit and full mouth restorations—are well positioned to ride this trend.

“Frontier is uniquely positioned in the industry due to their ability to produce a high volume of complex full arch and multi-unit crowns to a discerning base of global customers,” said Jonathan Bluth, Director and Co-Head of the Healthcare Group at Intrepid. “We applaud the Frontier team for revolutionizing the industry with a distinctive social media strategy and look forward to seeing what they can accomplish by partnering with O2.”

Deal Team Contacts

Jonathan Zucker, Managing Director and Head of Capital Markets

Jonathan Bluth, Director and Co-Head of Healthcare

Kyle Kearney, Associate

About Intrepid Investment Bankers

Intrepid provides M&A, capital raising and strategic advisory services to entrepreneurs and middle-market companies in various industry sectors. Our heritage breeds a culture that embraces teamwork, tenacity, and creativity to help our clients win big. We believe that every company has an entrepreneurial passion that drives it and a story that defines it. Our team delivers results through skillful positioning and relentless execution. Based in Los Angeles, Intrepid augments its international capabilities through its active participation in Oaklins, an exclusive global alliance of M&A advisory firms.

About Intrepid’s Healthcare Group

Intrepid’s Healthcare Group is dedicated to providing strategic advice in capital raises and mergers and acquisitions across a broad range of healthcare sectors, including physician practice management, diagnostics and labs, revenue cycle management, behavioral health, hospitals, IT, pharmacy, post-acute care, and medical devices. Our team maintains extensive relationships with strategic buyers and institutional investors across these sectors.

Media Contact

Andreea Popa, Director, Marketing & Communications